Overview

Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Evaluate the safety and general clinical response of desloratadine syrup in the relief of symptoms associated with perennial allergic rhinitis in Indonesian pediatric patients.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Desloratadine